Pharmacologic strategies for the prevention of acute renal failure;Pharmakologische prävention des akuten nierenversagens

Intensivmedizin und Notfallmedizin

Volumn 40, Issue 5, 2003, Pages 350-355

  Joannidis, M ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Acute renal failure; Human trials; Pharmacologic treatment; Prevention

Indexed keywords

ACETYLCYSTEINE; ADENOSINE RECEPTOR BLOCKING AGENT; FREE RADICAL; GLUCOSE; GLUTAMINE; HYPERTENSIVE FACTOR; INSULIN; MANNITOL; SELENIUM; THEOPHYLLINE;

ACUTE KIDNEY FAILURE; AMINO ACID SUBSTITUTION; CONFERENCE PAPER; CRUSH TRAUMA; GLUCOSE BLOOD LEVEL; HEMODYNAMICS; HUMAN; INCIDENCE; INFLAMMATION; INOTROPISM; INTENSIVE CARE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY PERFUSION; PATHOPHYSIOLOGY; PROPHYLAXIS; REGENERATION; SEPSIS; VASODILATATION;

EID: 0038166127     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00390-003-409-9     Document Type: Conference Paper

References (31)

1. Abassi ZA, Hoffman A, Better OS (1998) Acute renal failure complicating muscle crush injury. Semin Nephrol 18:558-565
2. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH (1997) Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336:828-834
3. Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R (1999) Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 27:1807-1813
4. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139-2143
5. Bellomo R, Giantomasso DD (2001) Noradrenaline and the kidney: friends or foes? Crit Care 5:294-298
6. Brezis M, Rosen S (1995) Hypoxia of the renal medulla - its implications for disease. N Engl J Med 332:647-655
7. Conesa EL, Valero F, Nadal JC, Fenoy FJ, Lopez B, Arregui B, Salom MG (2001) N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am J Physiol Regul Integr Comp Physiol 281:R730-R737
8. Erley CM, Duda SH, Rehfuss D, Scholtes B, Bock J, Muller C, Osswald H, Risler T (1999) Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant 14:1146-1149
9. Goligorsky MS, Noiri E, Kessler H, Romanov V (1997) Therapeutic potential of RGD peptides in acute renal injury. Kidney Int 51:1487-1492
10. Griffiths RD, Jones C, Palmer TE (1997) Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 13:295-302
11. Halpenny M, Rushe C, Breen P, Cunningham AJ, Boucher-Hayes D, Shorten GD (2002) The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 19:32-39
12. Herbert MK, Ginzel S, Muhlschlegel S, Weis KH (1999) Concomitant treatment with urodilatin (ularitide) does not improve renal function in patients with acute renal failure after major abdominal surgery - a randomized controlled trial. Wien Klin Wochenschr 111:141-147
13. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O'shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W (1999) Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 55:2423-2432
14. Holt S, Goodier D, Marley R, Patch D, Burroughs A, Fernando B, Harry D, Moore K (1999) Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet 353:294-295
15. Huber W, Ilgmann K, Page M, Hennig M, Schweigart U, Jeschke B, Lutilsky L, Weiss W, Salmhofer H, Classen M (2002) Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study. Radiology 223: 772-779
16. Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C (1989) Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 84:1757-1761
17. Joannidis M, Gstraunthaler G, Pfaller W (1990) Xanthine oxidase: evidence against a causative role in renal reperfusion injury. Am J Physiol 258: F232-F236
18. Joannidis M, Spokes K, Nakamura T, Faletto D, Cantley LG (1994) Regional expression of hepatocyte growth factor/c-met in experimental renal hypertrophy and hyperplasia. Am J Physiol 267:F231-F236
19. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M (2000) Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11:97-104
20. Lenz K, Hortnagl H, Druml W, Reither H, Schmid R, Schneeweiss B, Laggner A, Grimm G, Gerbes AL (1991) Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology 101:1060-1067
21. Mathur VS, Swan SK, Lambrecht LJ, Anjum S, Fellmann J, McGuire D, Epstein M, Luther RR (1999) The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 27:1832-1837
22. Mehta RL, Pascual MT, Soroko S, Chertow GM (2002) Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 288:2547-2553
23. Melin J, Hellberg O, Larsson E, Zezina L, Fellstrom BC (2002) Protective effect of insulin on ischemic renal injury in diabetes mellitus. Kidney Int 61:1383-1392
24. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H (2002) Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162:329-336
25. Redl-Wenzl EM, Armbruster C, Edelmann G, Fischl E, Kolacny M, Wechsler-Fordos A, Sporn P (1993) The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 19:151-154
26. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357:911-916
27. Solomon R, Werner C, Mann D, D'Elia J, Silva P (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420
28. Tepel M, van Der GM, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine [see comments]. N Engl J Med 343:180-184
29. Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure [see comments]. N Engl J Med 334:1448-1460
30. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
31. Van den BG, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P (2003) Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 31:359-366